DOSE PRESCRIPTION IN BORON NEUTRON-CAPTURE THERAPY

被引:12
作者
GUPTA, N
GAHBAUER, RA
BLUE, TE
WAMBERSIE, A
机构
[1] OHIO STATE UNIV,NUCL ENGN PROGRAM,COLUMBUS,OH 43210
[2] UNIV CATHOLIQUE LOUVAIN,CLIN ST LUC,B-1200 BRUSSELS,BELGIUM
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1994年 / 28卷 / 05期
关键词
BORON NEUTRON CAPTURE THERAPY (BNCT); DOSE PRESCRIPTION; TREATMENT TIME; NORMAL TISSUE TOLERANCE;
D O I
10.1016/0360-3016(94)90490-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this paper is to address some aspects of the many considerations that need to go into a dose prescription in boron neutron capture therapy (BNCT) for brain tumors; and to describe some methods to incorporate knowledge from animal studies and other experiments into the process of dose prescription. Materials and Methods: Previously, an algorithm to estimate the normal tissue tolerance to mixed high and low linear energy transfer (LET) radiations in BNCT was proposed. We have developed mathematical formulations and computational methods to represent this algorithm. Generalized models to fit the central axis dose rate components for an epithermal neutron field were also developed. These formulations and beam fitting models were programmed into spreadsheets to simulate two treatment techniques which are expected to be used in BNCT: a two-field bilateral scheme and a single-field treatment scheme. Parameters in these spreadsheets can be varied to represent the fractionation scheme used, the B-10 microdistribution in normal tissue, and the ratio of B-10 in tumor to normal tissue. Most of these factors have to be determined for a given neutron field and B-10 compound combination from large animal studies. The spreadsheets have been programmed to integrate all of the treatment-related information and calculate the location along the central axis where the normal tissue tolerance is exceeded first. This information is then used to compute the maximum treatment time allowable and the maximum tumor dose that may be delivered for a given BNCT treatment. Results and Conclusion: The effect of different treatment variables on the treatment time and tumor dose has been shown to be very significant. It has also been shown that the location of D-max shifts significantly, depending on some of the treatment variables-mainly the fractionation scheme used. These results further emphasize the fact that dose prescription in BNCT is very complicated and nonintuitive. The physician prescribing the dose would need to rely on some method, like the one developed here, to come up with an appropriate dose prescription.
引用
收藏
页码:1157 / 1166
页数:10
相关论文
共 10 条
  • [1] FAIRBRIDGE R W, 1990, P185
  • [2] GABEL D, 1990, EPAC 90, pS79
  • [3] GAHBAUER R, 1989, CLIN ASPECTS NEUTRON, P81
  • [4] GAHBAUER RA, 1990, PROGR NEUTRON CAPTUR, P589
  • [5] GAHBAUER RA, 1991, BORON NEUTRON CAPTUR, P123
  • [6] EFFECT OF HEAD PHANTOM SIZE ON B-10 AND H-1[N,GAMMA]H-2 DOSE DISTRIBUTIONS FOR A BROAD FIELD ACCELERATOR EPITHERMAL NEUTRON SOURCE FOR BNCT
    GUPTA, N
    NIEMKIEWICZ, J
    BLUE, TE
    GAHBAUER, R
    QU, TX
    [J]. MEDICAL PHYSICS, 1993, 20 (02) : 395 - 404
  • [7] RANDOMIZED NEUTRON DOSE SEARCHING STUDY FOR MALIGNANT GLIOMAS OF THE BRAIN - RESULTS OF AN RTOG STUDY
    LARAMORE, GE
    DIENERWEST, M
    GRIFFIN, TW
    NELSON, JS
    GRIEM, ML
    THOMAS, FJ
    HENDRICKSON, FR
    GRIFFIN, BR
    MYRIANTHOPOULOS, LC
    SAXTON, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (06): : 1093 - 1102
  • [8] 3-DIMENSIONAL RADIATION-DOSE DISTRIBUTION ANALYSIS FOR BORON NEUTRON-CAPTURE THERAPY
    WHEELER, FJ
    NIGG, DW
    [J]. NUCLEAR SCIENCE AND ENGINEERING, 1992, 110 (01) : 16 - 31
  • [9] WILKINSON L, 1989, SYSTAT SYSTEM STATIS
  • [10] ZAMENHOFF RG, 1989, BASIC LIFE SCI, V54, P289